Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis

Bone Marrow Transplant. 2006 Aug;38(3):249-51. doi: 10.1038/sj.bmt.1705415. Epub 2006 Jun 12.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Arthritis, Juvenile / therapy*
  • Child
  • Female
  • Humans
  • Macrophage Activation* / immunology
  • Male
  • Myeloablative Agonists / adverse effects
  • Stem Cell Transplantation / adverse effects*
  • Syndrome
  • Transplantation Conditioning / adverse effects*
  • Transplantation Conditioning / methods
  • Transplantation, Autologous
  • Vidarabine / adverse effects
  • Vidarabine / analogs & derivatives

Substances

  • Myeloablative Agonists
  • Vidarabine
  • fludarabine